Medizinische Universit├Ąt Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Marme, F; Hanusch, C; Furlanetto, J; Morris, P; Link, T; Denkert, C; Fasching, PA; Jackisch, C; Antolin, S; Solbach, C; Aftimos, P; Huober, J; Untch, M; Balic, M; Reinisch, M; Blohmer, JU; Concalves, A; Rey, J; Buchele, T; Loibl, S.
Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients (pts) with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant chemotherapy (NACT)
ONCOL RES TREAT. 2022; 45(SUPPL 3): 30-30. [Poster]
Web of Science


Authors Med Uni Graz:
Balic Marija

© Med Uni GrazImprint